SharkNinja, Inc. reports results for the quarter ended June 30 - Earnings Summary
SharkNinja, Inc. reports results for the quarter ended June 30 - Earnings Summary
SharkNinja, Inc. SN.N reported quarterly adjusted earnings of $1.26 per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of 97 cents. The mean expectation of ten analysts for the quarter was for earnings of $1.11 per share. Wall Street expected results to range from $1.04 to $1.17 per share.
Revenue rose 22.2% to $1.77 billion from a year ago; analysts expected $1.65 billion.
SharkNinja, Inc.'s reported EPS for the quarter was 92 cents.
The company reported quarterly net income of $129.82 million.
SharkNinja, Inc. shares had risen by 10.5% this quarter and gained 50.3% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 0.4% in the last three months.
In the last 30 days, there have been no negative revisions of earnings estimates
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 13 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
This summary was machine generated from LSEG data August 5 at 01:31 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Jun. 30 2026 | 1.11 | 1.26 | Beat |
Mar. 31 2026 | 1.03 | 1.09 | Beat |
Dec. 31 2025 | 1.80 | 1.93 | Beat |
Sep. 30 2025 | 1.35 | 1.50 | Beat |
Recent news on SharkNinja
See all newsHow one hacker used AI agents and a few thousand dollars to break into scores of sites
SharkNinja, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: SharkNinja Q2 Pretax Profit USD 163.693 Million
SharkNinja Q2 sales beat; raises FY26 net sales growth outlook
U.S. RESEARCH ROUNDUP- Datadog, Eli Lilly, Oracle